Diana Brainard
CIK 1818070 · Chief Executive Officer · last filed 2025-10-01
Diana Brainard is a Chief Executive Officer who has filed 42 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for NKTR, was dated Oct 1, 2025. Across all open-market trades the lifetime net is −$569.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.70M
2
42
-$569.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NKTR | Director | 28,560 | $59.38 | $1.70M | $0 | 4 | 2025-10-01 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | Chief Executive Officer | 723,363 | $9.81 | $7.10M | -$569.2K | 38 | 2024-11-20 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-01 | NKTR | Grant (A) | — | $0 | EDGAR |
| 2024-11-20 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −8,706 | -$4.8K | EDGAR |
| 2024-11-06 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −10,609 | -$9.2K | EDGAR |
| 2024-10-23 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −9,752 | -$7.6K | EDGAR |
| 2024-10-04 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −1,493 | -$1.2K | EDGAR |
| 2024-08-22 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −5,390 | -$4.0K | EDGAR |
| 2024-08-20 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −3,091 | -$2.3K | EDGAR |
| 2024-08-07 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −10,847 | -$8.0K | EDGAR |
| 2024-07-23 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −9,731 | -$7.3K | EDGAR |
| 2024-07-03 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −1,489 | -$1.1K | EDGAR |